AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglimin GM 3mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Knoll Pharmaceuticals Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Voglimin GM 3mg/500mg Tablet SR

DiaBeta-Duo 3mg/500mg extended-release tablets are classified as antidiabetic agents. This dual-action medication, prescribed for adult type 2 diabetes, effectively manages blood glucose. Consume DiaBeta-Duo with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue this medication even if feeling well or achieving good blood sugar control; abrupt cessation can lead to elevated glucose levels, potentially causing kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your healthcare provider. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals and carry readily-available glucose sources (e.g., sugary snacks or juice) to counteract hypoglycemia. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Voglimin GM 3mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Voglimin GM 3mg/500mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Voglimin GM 3mg/500mg Extended-Release Tablets with food.

Common Side effects of Voglimin GM 3mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Voglimin GM 3mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglimin GM 3mg/500mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. Administer this extended-release tablet with food.

How Voglimin GM 3mg/500mg Tablet SR works:

Voglimin GM 3mg/500mg sustained-release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Voglimin GM 3mg/500mg SR tablets is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Voglimin GM 3mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Voglimin GM 3mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Voglimin GM 3mg/500mg SR tablets to individuals with kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Voglimin GM 3mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney dysfunction. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Voglimin GM 3mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Initiation with a reduced dose is typical for those with mild to moderate liver disease; however, its use is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Voglimin GM 3mg/500mg Tablet SR :

Should you forget a dose of Voglimin GM 3mg/500mg SR Tablet, take it immediately if you remember. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Voglimin GM 3mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voglimin GM 3mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Voglimin GM 3mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Voglimin GM 3mg/500mg Tablet SR and seek immediate medical attention.
Voglimin GM 3mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Voglimin GM 3mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Voglimin GM 3mg/500mg Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Voglimin GM 3mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Voglimin GM 3mg/500mg SR tablets and alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Voglimin GM 3mg/500mg Tab...
46
MRP 56
17% off